"Portopulmonary hypertension (POPH/PPHTN) refers to pulmonary artery hypertension that develops in the setting of portal hypertension (with or without underlying liver disease). It falls under group 1.4 of the Dana point 2008 pulmonary hypertension classification system."
"Portopulmonary hypertension (POPH/PPHTN) refers to pulmonary artery hypertension that develops in the setting of portal hypertension (with or without underlying liver disease). It falls under group 1.4 of the Dana point 2008 pulmonary hypertension classification system."
"The prevalence of portopulmonary hypertension ranges from 2-5% in patients with liver cirrhosis."
"vasoactive substances (e.g. serotonin, interleukin-1, endothelin-1, and thromboxane) cause vasoconstriction and mitogenesis in pulmonary arteries, bypass the liver through portosystemic shunts or not effectively cleared by the diseased cirrhotic liver"
"portopulmonary hypertension (POPH)"
Expected headings
"Suggested diagnostic criteria"